Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
DHHC9–STRN4 Palmitoylation Drives YAP Metastasis
2026-09-01
This study identifies a DHHC9–STRN4 palmitoylation axis that activates YAP signaling and promotes adenocarcinoma migration and metastasis. Its combination of genetic, proteomic, functional, and pharmacological evidence positions DHHC9 as a candidate intervention point while highlighting the need to preserve phosphorylation readouts during mechanistic experiments.
-
Miltefosine: PI3K/Akt and Hematology Evidence
2026-09-01
Miltefosine, also known as hexadecyl 2-(trimethylazaniumyl)ethyl phosphate, is a research compound linked to PI3K/Akt inhibition and Ras/MEK/ERK activation. Product data support cell-based activity, while a peer-reviewed study reports neutrophil differentiation and hematopoietic recovery in leukopenia models.
-
Taxus chinensis Fruit, TLR4, and Neuroinflammation
2026-08-31
The reference study shows that Taxus chinensis fruit extract attenuates aging-associated behavioral deficits and hypothalamic neuroinflammation in a D-galactose mouse model, with effects linked to microglial TLR4/NF-κB/NLRP3 signaling. Its combination of behavioral, biochemical, cellular, mass-spectrometric, and docking analyses provides a useful framework for studying plant-derived modulation of inflammatory pathways while leaving direct target validation as an important next step.
-
NFIA Coordinates Bone Formation and Resorption
2026-08-31
Dong and colleagues identify NFIA as a previously unrecognized regulator of bone homeostasis that acts mainly in mesenchymal stem/progenitor cells. Conditional mouse models and mechanistic assays show that NFIA restrains RANKL-dependent bone resorption while also limiting osteoblastogenesis through SFRP1 and Wnt/β-catenin inhibition; loss of NFIA therefore reduces bone mass because the resorptive phenotype predominates.
-
Reactive Oxygen Species Assay Kit Workflow
2026-08-30
Build a reproducible live-cell ROS workflow with DCFH-DA, Rosup controls, and normalization strategies that distinguish oxidative signaling from cell loss. The approach translates findings from FLASH radiotherapy and EGCG nanoparticle research into practical assay design without overstating what fluorescence alone can prove.
-
Recombinant Mouse IFN-γ for MASH-HCC Assays
2026-08-29
Use Recombinant Mouse IFN-γ as a defined perturbation to test whether MASH-HCC cells retain the capacity to restore MHC-I antigen presentation after bile acid stress. This workflow combines dose-controlled cytokine biology with NLRC5-focused molecular readouts, helping distinguish reversible immune suppression from intrinsic antigen-presentation defects.
-
TCEP Hydrochloride for Capture-and-Release Assays
2026-08-28
TCEP hydrochloride combines water solubility, odorless handling, and thiol-free disulfide reduction for controlled protein and linker workflows. This article translates capture-and-release lateral flow research into practical assay development while showing how the same reagent supports digestion, structural analysis, and redox chemistry.
-
C8-HSL: From Quorum Sensing to Translational Biology
2026-08-28
N-octanoyl-L-Homoserine lactone, or C8-HSL, is more than a bacterial communication signal: emerging evidence connects it with host-cell signaling and cancer-relevant phenotypes. This thought-leadership guide outlines how translational researchers can use C8-HSL to bridge microbial pathogenicity research, biofilm formation regulation, virulence factor modulation, and infection biology research while maintaining appropriate evidentiary discipline.
-
Degarelix acetate: Workflow for GnRH Assays
2026-08-27
Degarelix acetate gives researchers a rapid, selective way to test GnRH receptor blockade, pituitary hormone regulation, and testosterone-dependent biology. This guide translates receptor assays and the long-term caprine study into practical dose selection, longitudinal sampling, and troubleshooting strategies for prostate cancer research and reproductive endocrinology.
-
FOXO3 Dual Metabolic Targeting in Liver Cancer
2026-08-27
The reference study identifies FOXO3 as a suppressor of both glycolysis and glutaminolysis in hepatocellular carcinoma through direct transcriptional repression of YAP. Its integrated cell, animal, and patient-derived organoid evidence supports the FOXO3/YAP axis as a mechanistically grounded strategy for limiting metabolic plasticity and HCC growth.
-
GANT61: A GLI Inhibitor for Ferroptosis Studies
2026-08-26
GANT61 is a selective GLI inhibitor for dissecting GLI1/2-dependent cancer biology. This article connects GLI-mediated transcription inhibition to the GLI2–PRDX1 ferroptosis axis and translates that mechanism into practical assay decisions.
-
Norovirus Co-opts NINJ1 for Selective Secretion
2026-08-26
Song et al. show that murine norovirus repurposes the membrane-rupture factor NINJ1 to release the viral NS1 protein through a caspase-3-dependent unconventional pathway. The study connects viral immune evasion with regulated cell death and identifies NINJ1 recruitment, oligomerization, and NS1 binding as key mechanistic steps.
-
Deuterated Degarelix Acetate: Synthesis and Significance
2026-08-25
The reference study reports a practical 13-step synthesis of deuterium-labeled degarelix acetate, using D2O/D3PO4-mediated labeling of a naphthylalanine precursor followed by peptide assembly. The resulting route provides a stable-isotope-labeled material intended to support absorption, distribution, metabolism, and excretion studies of this GnRH receptor antagonist.
-
MAPK10–KRT16 Signaling in NSCLC Metastasis
2026-08-25
The reference study identifies a phosphorylation-dependent MAPK10/KRT16/RNF213 pathway that limits non-small cell lung cancer metastasis by promoting KRT16 ubiquitination and proteasomal degradation. Its combination of mechanistic protein analysis, cellular motility assays, mouse rescue experiments, and clinical association data supports the axis as a candidate prognostic framework, while leaving important questions about specificity and therapeutic translation.
-
Rhodamine 123: Reading Transport Beyond Fluorescence
2026-08-24
Rhodamine 123 (chloride) is a powerful live-cell probe for dissecting uptake, efflux, and intracellular retention. This interpretation-first guide explains how to distinguish ABCB1/MDR1 activity from broader transporter effects and apply the dye alongside orthogonal evidence.